Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunosuppressants
Biotech
Taysha mulls tweaks to gene therapy trial after subject dies
The death overshadowed positive biomarker data on Taysha’s treatment for infantile onset GM2 gangliosidosis, a severe neurodegenerative disease.
Nick Paul Taylor
Jan 27, 2022 8:55am
Novartis scraps transplant trial after control beats study drug
Sep 3, 2021 7:17am
Gilead pens buyout option deal for Pionyr
Jun 23, 2020 9:05am
Takeda's CMV med outshines Roche's Valcyte in phase 2
Sep 24, 2019 10:27am
Zealand CSO steps up as chief of French biotech
Sep 6, 2019 8:20am
Regenerex gets new CEO, new funding and new name: Talaris
Apr 18, 2019 6:00am
